EP Plenary session - European Health Data Space

EP Plenary session - Framework for ensuring a secure and sustainable supply of critical raw materials

COP28 UAE - United Nations Climate Change Conference

Trilogue: Amendment to the Cyber Security Act

ENVI - Exchange of views with Dr Andrea AMMON, Director of the European Centre for Disease Prevention and Control (ECDC)

ITRE Committee meeting - Voting session

Belgian Presidency Ambassador Pierre CARTUYVELS meets with Cristian-Silviu BUSOI - ITRE committee Chair.

During the plenary session of the European Parliament in Brussels (08-11 February 2021), the MEPs debate the Oral question on the safety of the nuclear power plant in Ostrovets (Belarus). Opening session by Author and by Kadri SIMSON, European Commissioner for Energy. This transcription speech is the result of an automatic process. Check against delivery.

Safety of the nuclear power plant in Ostrovets (Belarus) - Oral question: Opening statements by Cristian-Silviu BUŞOI (EPP, RO), author and by Kadri SIMSON, European Commissioner for Energy

During the plenary session of the European Parliament in Brussels (08-11 February 2021), MEPs debate the state of play of the EU's COVID-19 Vaccination Strategy.

The state of play of the EU's COVID-19 vaccination strategy: MEPs debate (part 2)

Emer COOKE, Executive Director of the European Medicines Agency, answers questions posed by the members of the Committee on the Environment, Public Health and Food Safety on vaccine authorisation, availability and deployment.

Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency EP Committee on the Environment, Public Health and Food Safety: questions/answers with the MEPs

In 2020, the coronavirus pandemic has put European health systems under enormous pressure and gaps have been showed up in the way public health emergencies are addressed. The EU is working on how to secure access to COVID-19 vaccines for all and the Parliament supported speedy authorisation of safe vaccines. Also, MEPs paved the way for an effective EU health programme, called "EU4Health" (for 2021-2027), which aims to fill these gaps. EU4Health's three main priorities are: tackling cross-border health threats; making medicines available and affordable; and strengthening health systems.

European Parliament Review 2020 - EU response to COVID-19

During the plenary session in Brussels (11-13 November 2020) MEPs debate the programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”). Opening statements by Cristian-Silviu BUŞOI (EPP, RO), Rapporteur and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety This transcription speech is the result of an automatic process. Check Against delivery

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): Opening statements by Cristian-Silviu BUŞOI (EPP, RO), Rapporteur and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety

During the plenary session (11-13/11/2020) of the European Parliament in Brussels, MEPs discussed and adopted its position on the legislative proposal for the so-called “EU4Health Programme”, which aims to increase EU capacities to help member states deal with health crises such as COVID-19.

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): extracts from the debate (12/11), from the vote and illustration shots

Cristian Silviu BUSOI (EPP, RO), rapporteur, makes a statement on the proposed “EU4Health Programme”, which aims to promote health and make national health systems more resilient, in the EUropean Parlaiment in Brussels. EU4Health is EU’s response to COVID-19, which has had a major impact on medical and healthcare staff, patients and health systems in Europe. EU4Health will provide funding to EU countries, health organisations and NGOs. Funding will be open for applications in 2021.

Establishment of a Programme for the Union's action in the field of health for the period 2021-2027 and repealing Regulation: statement by Cristian Silviu BUSOI (EPP, RO), rapporteur

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 2 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 2/ 2 Q&A with ENVI and ITRE Members.

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Conclusion and closing remarks by Pascal CANFIN (Renew, FR), ENVI Chair and by Cristian-Silviu BUŞOI (EPP, RO), ITRE Chair.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Conclusion and closing remarks by the Chairs

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 1 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 1/2 Q&A with ENVI and ITRE Members.

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Welcome and opening remarks by Pascal CANFIN (Renew,FR), ENVI Chair and by Cristian-Silviu BUŞOI (EPP,RO), ITRE Chair. This transcription speech is the result of an automatic process. Check against delivery.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Welcome and opening remarks by the Chairs

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Presentation by the speakers. This transcription speech is the result of an automatic process. Check against delivery.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Presentation by the speakers.

As part of efforts to achieve the goal of a carbon-neutral EU by 2050, Committee on Industry, Research and Energy (ITRE) vote on proposals to increase energy storage capacity and guarantee the security of energy supply, with renewables making up an increasingly larger part of Europe’s energy mix. MEPs should present ideas to develop storage through hydrogen, batteries and other solutions.

Establishing the Just Transition Fund - report by Jerzy BUZEK (EPP, PL) / A comprehensive European approach to energy storage - report by Claudia GAMON (Renew, AT): ambiance shots and result of the votes

Members of the EP Committee on the Environment, Public Health and Food Safety (ENVI) debate with Hans KLUGE, WHO Regional Director for Europe, during an exchange of views on the fight against COVID-19 and the global response to it. Increased coordination and cooperation at global level are crucial to better prevent and tackle pandemics. MEPs debate - part 2 followed by the response by Hans KLUGE, WHO Regional Director for Europe

Exchange of views with Hans KLUGE, WHO Regional Director for Europe: MEPs debate (part 2) and response by Hans KLUGE

During a meeting of the EP Committee on Industry, Research and Energy (ITRE), Members vote on the revision of the guidelines for trans-European energy infrastructure in the European Parliament in Brussels. Statement by Cristian-Silviu BUŞOI (EPP, RO), Chair of the Committee on Industry, Research and Energy. The results of the vote are 55 in favour, 15 against, 0 abstentions. The resolution is adopted.

Revision of the guidelines for trans-European energy infrastructure: extracts from the vote

During the extraordinary EP plenary sitting in Brussels, MEPs debate the “European Green Deal” to make the EU the first climate-neutral continent.

Debate on the European Green Deal: MEPs debate (2/2)

Stella KYRIAKIDES, Commissioner-designate for Health, is heard by the Committee on Environment (ENVI) in association with the Committee on Agriculture and Rural Development (AGRI) of the European Parliament in Brussels for a hearing to test her general competences, European commitment and specific expertise related to her portfolio. Statements by Dolors MONTSERRAT (EPP, ES), Jytte GUTELAND (S&D, SE), Pascal CANFIN (RE, FR), Cristian-Silviu BUŞOI (EPP, RO) and Stella KYRIAKIDES, Commissioner-designate for Health.

Hearing of Stella KYRIAKIDES, Commissioner-designate, Health: extracts from the hearing

On 1st October 2019, Stella KYRIAKIDES, from Cyprus, Commissioner-designate for Health, is heard by the Committee on Environment, Public Health and Food Safety (ENVI) in association with the Committee on Agriculture and Rural Development (AGRI) of the European Parliament in Brussels to test her general competences, European commitment and specific expertise related to her portfolio. Second round of questions

94 results